Review article · 2025 · Open access

CAR-based cell therapy for autoimmune diseases

Xiu Li, Chao sheng He, Xiuli Wang, Guoying Xu, Yachao Xie, Xin-Yu Ying

Frontiers in Immunology, 16, 1613622 · Published 18 September 2025 · DOI 10.3389/fimmu.2025.1613622

Open PDFView at the publisherCite this paper

In brief

“CAR-based cell therapy for autoimmune diseases” is a 2025 review article by Xiu Li and 5 co-authors, published in Frontiers in Immunology. OpenAlex counts 17 citations as of 19 November 2026, which puts it in the top 8% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Immunology.

Citations
17
Most cited in
2026 (15)
Field-weighted impact
1.56
References
109
Authors
6

Abstract

Chimeric antigen receptor (CAR)-based cell therapies, initially designed for oncology, are rapidly advancing as a novel and highly targeted approach for the treatment of autoimmune diseases (AIDs). By harnessing engineered immune cells to eliminate autoreactive immune components or restore immune homeostasis, CAR-based strategies offer new avenues beyond conventional immunosuppression. In this review, we summarize current applications of CAR-T cells in autoimmune diseases, and discuss emerging approaches including CAR-Tregs, chimeric autoantibody receptor T (CAAR-T) cells, CAR-NK cells, and CAR-macrophages. We also describe advances in CAR design, including antigen selection, co-stimulatory domains, and safety control mechanisms, which are critical for improving therapeutic precision and reducing side effects. In addition, we highlight the role of synthetic biology in enabling more flexible and controllable CAR functions. Finally, we discuss the main challenges facing clinical translation, such as antigen specificity, long-term persistence, and manufacturing feasibility. These developments collectively support the potential of CAR-based therapies as a next-generation option for autoimmune disease treatment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Li, X., He, C. S., Wang, X., Xu, G., Xie, Y., & Ying, X.-Y. (2025). CAR-based cell therapy for autoimmune diseases. Frontiers in Immunology, 16, 1613622. https://doi.org/10.3389/fimmu.2025.1613622

MLA 9

Li, Xiu, et al. “CAR-based cell therapy for autoimmune diseases.” Frontiers in Immunology, vol. 16, 2025, p. 1613622. https://doi.org/10.3389/fimmu.2025.1613622.

Chicago

Li, Xiu, Chao sheng He, Xiuli Wang, Guoying Xu, Yachao Xie, and Xin-Yu Ying. 2025. “CAR-based cell therapy for autoimmune diseases.” Frontiers in Immunology 16: 1613622. https://doi.org/10.3389/fimmu.2025.1613622.

Harvard

Li, X. et al. (2025) ‘CAR-based cell therapy for autoimmune diseases’, Frontiers in Immunology, 16, p. 1613622. doi:10.3389/fimmu.2025.1613622.

IEEE

X. Li, C. S. He, X. Wang, G. Xu, Y. Xie, and X.-Y. Ying, “CAR-based cell therapy for autoimmune diseases,” Frontiers in Immunology, vol. 16, p. 1613622, 2025, doi: 10.3389/fimmu.2025.1613622.

BibTeX

@article{li2025based,
  title     = {{CAR-based cell therapy for autoimmune diseases}},
  author    = {Li, Xiu and He, Chao sheng and Wang, Xiuli and Xu, Guoying and Xie, Yachao and Ying, Xin-Yu},
  journal   = {Frontiers in Immunology},
  year      = {2025},
  volume    = {16},
  pages     = {1613622},
  doi       = {10.3389/fimmu.2025.1613622},
  url       = {https://doi.org/10.3389/fimmu.2025.1613622}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • chimeric antigen receptor
  • autoimmune disease
  • chimeric antigen receptor T cells
  • CAR-Tregs
  • CAR-NK cells
  • CAR macrophages
  • costimulatory domains
  • synthetic biology

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Li, X., He, C. S., Wang, X., Xu, G., Xie, Y., & Ying, X.-Y. (2025). CAR-based cell therapy for autoimmune diseases. Frontiers in Immunology, 16, 1613622. https://doi.org/10.3389/fimmu.2025.1613622

How many times has this paper been cited?

17 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Immunology: sign in and open the PDF from this page.

Who wrote this paper?

Xiu Li, Chao sheng He, Xiuli Wang, Guoying Xu, Yachao Xie, Xin-Yu Ying.

What is the DOI of this paper?

10.3389/fimmu.2025.1613622, permanently at https://doi.org/10.3389/fimmu.2025.1613622. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.